Autoantibody serum levels in patients with SAPHO syndrome with at least 1 autoantibody. Numbers in parentheses are percentages.
| ANA ≥ 1/80 | |
| All patients | 37 (36.7) |
| Patients who never took ANA-inducing drugs | 24 (26.6) |
| ANA ≥ 1/160 | |
| All patients | 14 (15.5) |
| Patients who never took ANA-inducing drugs | 10 (11.1) |
| Anti-dsDNA Ab1 | 0 (0) |
| Anti-Tg Ab | 2 (2.2) |
| Anti-TPO Ab | 2 (2.2) |
| Anti-ENA Ab (anti-SSA Ab) | 1 (1.1) |
| Antismooth muscle Ab | 4 (4.4) |
| Antimitochondria Ab | 0 (0) |
| Antigastric parietal cell Ab | 3 (3.3) |
| Anti-LKM Ab | 0 (0) |
| Anti-CCP Ab2 | 0 (0) |
| Antiendomysium Ab3 | 0 (0) |
↵1 22 patients tested.
↵2 69 patients tested.
↵3 55 patients tested. SAPHO: synovitis, acne, pustulosis, hyperostosis, osteitis; ANA: antinuclear antibody; dsDNA: double-stranded DNA; Ab: antibody; anti-Tg: antithyroid globulin; anti-TPO: antithyroid peroxydase; anti-ENA: antiextractable nuclear antigens; anti-LKM: anti-liver-kidney microsome; anti-CCP: anticyclic citrullinated peptide.